SKP2 and acute promyelocytic leukemia: When NB4 cells were treated with ATRA and GSK3β inhibitors, the expression of Skp2 was down-regulated, while the expression of JunB was significantly induced by accelerating the degradation of PML-RARα, which contributed to the eradication of APL(Dan et al., 2022).